John Nuss, CHIEF SCIENTIFIC OFFICER at Ventyx Biosciences, Inc. (VTYX), sold 12,675 shares at $7.72 ($98K) on 2025-12-18, disclosed to the SEC on 2025-12-19.
Seasonal sale ($98k) by CHIEF SCIENTIFIC OFFICER — this insider has traded VTYX in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |
| VTYX | SELL | 2023-12-21 | $37K | — | Filing → |